Concomitant Filled Prescriptions of Oxymorphone or Oxycodone with CYP3A Inhibitors and Inducers

Project Title Concomitant Filled Prescriptions of Oxymorphone or Oxycodone with CYP3A Inhibitors and Inducers
Date
Tuesday, May 26, 2020
Location

J Manag Care Spec Pharm. 2020 May 26. doi.org/10.18553/jmcp.2020.26.5.668

Description

The objective of this manuscript was to assess the relative frequency with which oxymorphone and oxycodone (a CYP3A-metabolized opioid analgesic) were each prescribed to patients concomitantly receiving CYP3A-modifying drugs (i.e., inducers and inhibitors) to characterize opioid-prescribing patterns in patients at risk for CYP3A-related drug interactions.

Corresponding Author

Judith C. Maro, Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts.
Email: judy_maro@harvardpilgrim.org

Authors

D. Tyler Coyle, Tiffany S. Woodworth, David Moeny, Judy Staffa, Tamra Meyer, Corinne Woods, Emily C. Welch, Kevin Haynes, Sengwee Toh, Judith C. Maro

Related Assessments
Concomitant Use of Opioid Analgesics and Cytochrome P450 (CYP) Inhibitors and Inducers
Publication Type
Publication
Scroll to Top